Literature DB >> 2025728

Antibodies to endothelial cells in dermatomyositis: association with interstitial lung disease.

R Cervera1, G Ramírez, J Fernández-Solà, D D'Cruz, J Casademont, J M Grau, R A Asherson, M A Khamashta, A Urbano-Márquez, G R Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2025728      PMCID： PMC1669229          DOI： 10.1136/bmj.302.6781.880-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Microvascular changes in early and advanced dermatomyositis: a quantitative study.

Authors:  A M Emslie-Smith; A G Engel
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

2.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

3.  Microvascular deposition of complement membrane attack complex in dermatomyositis.

Authors:  J T Kissel; J R Mendell; K W Rammohan
Journal:  N Engl J Med       Date:  1986-02-06       Impact factor: 91.245
  3 in total
  8 in total

Review 1.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

2.  Anti-endothelial cell antibody, thrombomodulin, and von Willebrand factor in idiopathic inflammatory myopathies.

Authors:  K V Salojin; A Bordron; E L Nassonov; V Z Shtutman; N G Guseva; A A Baranov; I N Targoff; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

Review 3.  Anti-endothelial cell antibodies and autoimmune diseases.

Authors:  N Del Papa; D Gambini; P L Meroni
Journal:  Clin Rev Allergy       Date:  1994

4.  The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study.

Authors:  David Fiorentino; Lorinda Chung; Jeff Zwerner; Antony Rosen; Livia Casciola-Rosen
Journal:  J Am Acad Dermatol       Date:  2011-04-29       Impact factor: 11.527

5.  High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.

Authors:  M Basta; M C Dalakas
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

6.  Serum immunoglobulin G reactive with endothelial cells in inflammatory bowel disease.

Authors:  A M Sawyerr; B E Pottinger; C O Savage; N J Bradley; M Hudson; A J Wakefield; J D Pearson; R E Pounder
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

Review 7.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

8.  Jejunal perforation complicating dermatomyositis.

Authors:  Donghyoun Lee; Woo Seong Jeong; Chang Lim Hyun; Jinseok Kim
Journal:  Int J Surg Case Rep       Date:  2019-04-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.